These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 18045304)

  • 1. Roles of specific cytokines in bone remodeling and hematopoiesis in Gaucher disease.
    Yoshino M; Watanabe Y; Tokunaga Y; Harada E; Fujii C; Numata S; Harada M; Tajima A; Ida H
    Pediatr Int; 2007 Dec; 49(6):959-65. PubMed ID: 18045304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of M-CSF, sCD14 and IL8 in type 1 Gaucher disease.
    Hollak CE; Evers L; Aerts JM; van Oers MH
    Blood Cells Mol Dis; 1997 Aug; 23(2):201-12. PubMed ID: 9236158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical markers of bone turnover as tools in the evaluation of skeletal involvement in patients with type 1 Gaucher disease.
    Drugan C; Jebeleanu G; Grigorescu-Sido P; Caillaud C; Craciun AM
    Blood Cells Mol Dis; 2002; 28(1):13-20. PubMed ID: 11814307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markers of bone turnover in Gaucher disease: modeling the evolution of bone disease.
    van Dussen L; Lips P; Everts VE; Bravenboer N; Jansen ID; Groener JE; Maas M; Blokland JA; Aerts JM; Hollak CE
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2194-205. PubMed ID: 21543432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of bone metabolism in seven patients with Gaucher disease treated consecutively with imiglucerase and miglustat.
    Mikosch P; Reed M; Baker R; Holloway B; Berger L; Mehta AB; Hughes DA
    Calcif Tissue Int; 2008 Jul; 83(1):43-54. PubMed ID: 18553043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cathepsin K as a biomarker of bone involvement in type 1 Gaucher disease].
    Bobillo Lobato J; Durán Parejo P; Núñez Vázquez RJ; Jiménez Jiménez LM
    Med Clin (Barc); 2015 Oct; 145(7):281-7. PubMed ID: 25662720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marker alterations in patients with type 1 Gaucher disease.
    Ciana G; Martini C; Leopaldi A; Tamaro G; Katouzian F; Ronfani L; Bembi B
    Calcif Tissue Int; 2003 Mar; 72(3):185-9. PubMed ID: 12522660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmenopausal changes in serum cytokine levels and hormone replacement therapy.
    Kamada M; Irahara M; Maegawa M; Ohmoto Y; Takeji T; Yasui T; Aono T
    Am J Obstet Gynecol; 2001 Feb; 184(3):309-14. PubMed ID: 11228479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of clinical response and bone biochemical markers in patients with ankylosing spondylitis taking etanercept.
    Woo JH; Lee HJ; Sung IH; Kim TH
    J Rheumatol; 2007 Aug; 34(8):1753-9. PubMed ID: 17610317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
    Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
    Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of Bone Turnover Markers and Cytokines to High-Intensity Low-Impact Exercise.
    Mezil YA; Allison D; Kish K; Ditor D; Ward WE; Tsiani E; Klentrou P
    Med Sci Sports Exerc; 2015 Jul; 47(7):1495-502. PubMed ID: 25373482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage colony-stimulating factor and interleukin-6 release by periprosthetic cells stimulates osteoclast formation and bone resorption.
    Neale SD; Sabokbar A; Howie DW; Murray DW; Athanasou NA
    J Orthop Res; 1999 Sep; 17(5):686-94. PubMed ID: 10569477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periarticular bone gain at proximal interphalangeal joints and changes in bone turnover markers in response to tumor necrosis factor inhibitors in rheumatoid and psoriatic arthritis.
    Szentpetery A; McKenna MJ; Murray BF; Ng CT; Brady JJ; Morrin M; Radovits B; Veale DJ; Fitzgerald O
    J Rheumatol; 2013 May; 40(5):653-62. PubMed ID: 23457381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating levels of interleukin-6 and tumor necrosis factor-alpha are elevated in primary hyperparathyroidism and correlate with markers of bone resorption--a clinical research center study.
    Grey A; Mitnick MA; Shapses S; Ellison A; Gundberg C; Insogna K
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3450-4. PubMed ID: 8855783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of cytokines in the changes in bone turnover following bone marrow transplantation.
    Lee WY; Kang MI; Oh ES; Oh KW; Han JH; Cha BY; Lee KW; Son HY; Kang SK; Kim CC
    Osteoporos Int; 2002 Jan; 13(1):62-8. PubMed ID: 11878457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of bone mineral density and turnover in patients with cystic fibrosis: associations between the IGF system and inflammatory cytokines.
    Street ME; Spaggiari C; Ziveri MA; Volta C; Federico G; Baroncelli GI; Bernasconi S; Saggese G
    Horm Res; 2006; 66(4):162-8. PubMed ID: 16804317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.
    Rioja I; Hughes FJ; Sharp CH; Warnock LC; Montgomery DS; Akil M; Wilson AG; Binks MH; Dickson MC
    Arthritis Rheum; 2008 Aug; 58(8):2257-67. PubMed ID: 18668547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum osteocalcin and bone alkaline phosphatase in healthy children in relation to age and gender].
    Ambroszkiewicz J; Gajewska J; Laskowska-Klita T
    Med Wieku Rozwoj; 2002; 6(3):257-65. PubMed ID: 12637780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncoupling of osteoblast-osteoclast regulation in a chemical murine model of Gaucher disease.
    Mucci JM; Suqueli García F; de Francesco PN; Ceci R; Di Genaro S; Fossati CA; Delpino MV; Rozenfeld PA
    Gene; 2013 Dec; 532(2):186-91. PubMed ID: 24076352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytokines as markers of osteolysis in the diagnostics of patients with bone metastases].
    Groblewska M; Mroczko B; Czygier M; Szmitkowski M
    Postepy Hig Med Dosw (Online); 2008 Dec; 62():668-75. PubMed ID: 19188882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.